Radiation combined with ultrasound and microbubbles: A potential novel strategy for cancer treatment.

Acid sphingomyelinase Ceramide Endothelial cells Radiation Radiosensitization Tumor vasculature Ultrasound-Stimulated Microbubbles

Journal

Zeitschrift fur medizinische Physik
ISSN: 1876-4436
Titre abrégé: Z Med Phys
Pays: Germany
ID NLM: 100886455

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 11 01 2023
revised: 31 03 2023
accepted: 11 04 2023
medline: 18 9 2023
pubmed: 17 8 2023
entrez: 16 8 2023
Statut: ppublish

Résumé

Cancer is one of the leading causes of death worldwide. Several emerging technologies are helping to battle cancer. Cancer therapies have been effective at killing cancer cells, but a large portion of patients still die to this disease every year. As such, more aggressive treatments of primary cancers are employed and have been shown to be capable of saving a greater number of lives. Recent research advances the field of cancer therapy by employing the use of physical methods to alter tumor biology. It uses microbubbles to enhance radiation effect by damaging tumor vasculature followed by tumor cell death. The technique can specifically target tumor volumes by conforming ultrasound fields capable of microbubbles stimulation and localizing it to avoid vascular damage in surrounding tissues. Thus, this new application of ultrasound-stimulated microbubbles (USMB) can be utilized as a novel approach to cancer therapy by inducing vascular disruption resulting in tumor cell death. Using USMB alongside radiation has showed to augment the anti-vascular effect of radiation, resulting in enhanced tumor response. Recent work with nanobubbles has shown vascular permeation into intracellular space, extending the use of this new treatment method to potentially further improve the therapeutic effect of the ultrasound-based therapy. The significant enhancement of localized tumor cell kill means that radiation-based treatments can be made more potent with lower doses of radiation. This technique can manifest a greater impact on radiation oncology practice by increasing treatment effectiveness significantly while reducing normal tissue toxicity. This review article summarizes the past and recent advances in USMB enhancement of radiation treatments. The review mainly focuses on preclinical findings but also highlights some clinical findings that use USMB as a therapeutic modality in cancer therapy.

Identifiants

pubmed: 37586962
pii: S0939-3889(23)00049-1
doi: 10.1016/j.zemedi.2023.04.007
pmc: PMC10517408
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

407-426

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier GmbH.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Br J Radiol. 2013 Apr;86(1024):20130044
pubmed: 23403455
World J Gastroenterol. 2010 Jul 28;16(28):3584-91
pubmed: 20653069
Crit Rev Biomed Eng. 2006;34(2):105-61
pubmed: 16749890
Cancer Res. 2000 Jan 15;60(2):321-7
pubmed: 10667583
Lancet Oncol. 2009 Jul;10(7):718-26
pubmed: 19573801
Ultrasound Med Biol. 2004 Sep;30(9):1217-22
pubmed: 15550325
J Pharm Sci. 2019 Sep;108(9):3091-3098
pubmed: 31095958
Ultrasound Med Biol. 2021 Jun;47(6):1465-1474
pubmed: 33653626
Eur J Echocardiogr. 2004 Aug;5(4):245-56
pubmed: 15219539
Clin Chem. 2019 Oct;65(10):1228-1238
pubmed: 31315901
Chin J Cancer Res. 2018 Oct;30(5):553-563
pubmed: 30510367
Pediatr Radiol. 2021 Nov;51(12):2117-2127
pubmed: 34117892
Ann Surg Oncol. 2007 Mar;14(3):1237-42
pubmed: 17187168
Int J Nanomedicine. 2012;7:3309-18
pubmed: 22802689
Semin Thromb Hemost. 2020 Jul;46(5):545-552
pubmed: 31096311
Sci Rep. 2023 Aug 21;13(1):13566
pubmed: 37604988
Antioxid Redox Signal. 2014 Jul 10;21(2):251-9
pubmed: 24180216
Science. 2001 Jul 13;293(5528):227-8
pubmed: 11452105
Adv Exp Med Biol. 2016;880:243-61
pubmed: 26486342
Int J Nanomedicine. 2018 Oct 04;13:6049-6058
pubmed: 30323592
J Clin Oncol. 2012 Jun 10;30(17):2046-54
pubmed: 22547592
Cancer Cell. 2005 Aug;8(2):89-91
pubmed: 16098459
Ultrason Sonochem. 2017 Jul;37:279-285
pubmed: 28427634
Nanoscale. 2020 Nov 7;12(41):21420-21428
pubmed: 33079108
Theranostics. 2023 Jan 1;13(1):250-266
pubmed: 36593952
Mol Biol Rep. 2018 Dec;45(6):2935-2940
pubmed: 30311129
Science. 2003 May 16;300(5622):1155-9
pubmed: 12750523
Science. 2001 Jul 13;293(5528):293-7
pubmed: 11452123
Oncotarget. 2015 Mar 10;6(7):4663-76
pubmed: 25609199
Acta Radiol. 2022 Oct;63(10):1433-1440
pubmed: 34463146
Ultrason Sonochem. 2017 Mar;35(Pt A):176-184
pubmed: 27707644
Langmuir. 2019 Aug 6;35(31):10068-10078
pubmed: 30827115
Abdom Radiol (NY). 2018 Apr;43(4):960-976
pubmed: 29450615
Angew Chem Int Ed Engl. 2003 Jul 21;42(28):3218-35
pubmed: 12876730
ACS Appl Mater Interfaces. 2020 Jul 1;12(26):29085-29093
pubmed: 32501014
Clin Oncol (R Coll Radiol). 2013 Oct;25(10):578-85
pubmed: 23849504
Ultrasound Med Biol. 2012 Aug;38(8):1363-71
pubmed: 22633269
J Clin Oncol. 2015 Jun 10;33(17):1889-94
pubmed: 25667295
Br J Radiol. 2018 Feb;91(1083):20170641
pubmed: 29168922
Oncotarget. 2019 Jan 01;10(1):6-7
pubmed: 30713596
Pharmaceutics. 2020 Mar 01;12(3):
pubmed: 32121484
J Clin Invest. 2002 Jul;110(1):3-8
pubmed: 12093880
Nat Commun. 2020 Jul 30;11(1):3801
pubmed: 32732879
Pharmacol Res. 2003 May;47(5):401-7
pubmed: 12676514
Ther Adv Med Oncol. 2018 Jan 18;10:1758834017742575
pubmed: 29383033
RSC Adv. 2021 Apr 6;11(21):12915-12928
pubmed: 35423829
Proc Natl Acad Sci U S A. 2012 Jul 24;109(30):E2033-41
pubmed: 22778441
Cancer Cell. 2005 Aug;8(2):99-110
pubmed: 16098463
J Immunother Cancer. 2022 Mar;10(3):
pubmed: 35236741
Surgery. 2009 Mar;145(3):286-93
pubmed: 19231581
Clin Cancer Res. 2019 Dec 15;25(24):7576-7584
pubmed: 31540976
Pharmaceutics. 2020 Oct 14;12(10):
pubmed: 33066531
Ultrason Sonochem. 2019 Apr;52:512-521
pubmed: 30642801
Radiology. 2021 Feb;298(2):450-457
pubmed: 33320067
Sci Rep. 2023 Mar 18;13(1):4487
pubmed: 36934140
J Hematol Oncol. 2020 Jun 22;13(1):81
pubmed: 32571374
Sci Rep. 2019 Feb 4;9(1):1352
pubmed: 30718594
Oncoscience. 2016 Mar 24;3(3-4):98-108
pubmed: 27226983
Int J Mol Sci. 2020 Dec 07;21(23):
pubmed: 33297519
Front Pharmacol. 2019 May 31;10:610
pubmed: 31214033
Sci Rep. 2020 Feb 26;10(1):3470
pubmed: 32103105
Cancers (Basel). 2019 Nov 08;11(11):
pubmed: 31717326
Ultrason Sonochem. 2023 Feb;93:106291
pubmed: 36640460
Cancer Lett. 2017 Dec 28;411:100-105
pubmed: 28969964
Cancer Immunol Immunother. 2017 Feb;66(2):247-258
pubmed: 27585790
Int J Mol Sci. 2022 Mar 05;23(5):
pubmed: 35269988
Cancer Immunol Res. 2018 Sep;6(9):990-1000
pubmed: 30181337
Prostaglandins Other Lipid Mediat. 2001 Apr;64(1-4):123-34
pubmed: 11324702
Cancer Cell Int. 2019 Nov 14;19:295
pubmed: 31807117
Br J Cancer. 2021 Jan;124(2):359-367
pubmed: 32929195
Int J Mol Sci. 2022 Jun 15;23(12):
pubmed: 35743121
Front Oncol. 2020 Apr 21;10:562
pubmed: 32373534
Immunology. 2013 Feb;138(2):105-15
pubmed: 23216602
Mol Cancer Res. 2006 Feb;4(2):61-70
pubmed: 16513837
Ther Deliv. 2016;7(2):117-38
pubmed: 26769397
Br J Cancer. 2023 Mar;128(5):715-725
pubmed: 36463323
Expert Rev Anticancer Ther. 2004 Apr;4(2):321-7
pubmed: 15056061
J Acoust Soc Am. 2013 Aug;134(2):1695-701
pubmed: 23927210
J Control Release. 2020 Jul 10;323:12-23
pubmed: 32302759
Bioeng Transl Med. 2020 Sep 07;6(1):e10183
pubmed: 33532585
Ultrasound Med Biol. 2014 Jun;40(6):1260-72
pubmed: 24486236
Photoacoustics. 2020 Jul 25;20:100201
pubmed: 32775198
Hum Gene Ther. 2019 Apr;30(4):402-412
pubmed: 30693795
Cell. 1996 Jul 26;86(2):189-99
pubmed: 8706124
Semin Cancer Biol. 2022 Feb;79:44-57
pubmed: 32623044
J Hematol Oncol. 2020 Jul 28;13(1):105
pubmed: 32723363
PLoS One. 2017 Jul 26;12(7):e0181951
pubmed: 28746357
Cancer Treat Rev. 2012 Aug;38(5):346-53
pubmed: 21924838
Interface Focus. 2015 Oct 6;5(5):20150019
pubmed: 26442143
Radiology. 2011 Apr;259(1):39-56
pubmed: 21436096
J Clin Oncol. 2015 Apr 1;33(10):1191-6
pubmed: 25713437
Dis Model Mech. 2014 Mar;7(3):363-72
pubmed: 24487407
J Transl Med. 2007 Jul 11;5:34
pubmed: 17625013
Biomed Pharmacother. 2020 Apr;124:109821
pubmed: 31962285
J Immunother. 2007 Nov-Dec;30(8):825-30
pubmed: 18049334
J Vasc Surg. 2017 Jul;66(1):266-274
pubmed: 28390769
Cancer Biol Ther. 2005 Sep;4(9):979-86
pubmed: 16096366
J Immunother Cancer. 2020 Jan;8(1):
pubmed: 31940590
J Transl Med. 2012 Nov 11;10:221
pubmed: 23140567
BMC Cancer. 2018 Apr 6;18(1):395
pubmed: 29625593
Front Pharmacol. 2020 Jul 15;11:1057
pubmed: 32760276
J Natl Cancer Inst. 2018 Sep 1;110(9):1009-1018
pubmed: 29506145
Adv Sci (Weinh). 2019 Jun 17;6(17):1900557
pubmed: 31508275
Sci Rep. 2018 Jun 21;8(1):9474
pubmed: 29930290
J Hematol Oncol. 2018 Aug 16;11(1):104
pubmed: 30115069
Ann Oncol. 2013 Jan;24(1):75-83
pubmed: 22858559
Small. 2021 May;17(20):e2100345
pubmed: 33811441
Future Oncol. 2015;11(7):1093-108
pubmed: 25804124
Cancers (Basel). 2019 Sep 06;11(9):
pubmed: 31500214
Microvasc Res. 2007 Sep-Nov;74(2-3):72-84
pubmed: 17560615
Eur J Radiol. 2017 Nov;96:65-73
pubmed: 29103478
Theranostics. 2019 Oct 15;9(25):7749-7758
pubmed: 31695798
PLoS One. 2020 Sep 25;15(9):e0239456
pubmed: 32976517
Ultrasound Med Biol. 2019 Dec;45(12):3232-3245
pubmed: 31530419
Technol Cancer Res Treat. 2013 Feb;12(1):53-60
pubmed: 22905807
Phys Med Biol. 2009 Mar 21;54(6):R27-57
pubmed: 19229096
IUBMB Life. 2006 Aug;58(8):467-72
pubmed: 16916784
Cancer Cell. 2004 May;5(5):429-41
pubmed: 15144951
Cell Physiol Biochem. 2018;48(4):1530-1542
pubmed: 30071515
PLoS One. 2014 Apr 15;9(4):e93888
pubmed: 24736631
Lancet Oncol. 2014 Jun;15(7):700-12
pubmed: 24831977
J Control Release. 2020 Oct 10;326:75-90
pubmed: 32554041
Int J Hyperthermia. 2007 Mar;23(2):165-71
pubmed: 17578340
IEEE Trans Ultrason Ferroelectr Freq Control. 2001 Nov;48(6):1483-94
pubmed: 11800109
Adv Drug Deliv Rev. 2008 Jun 30;60(10):1153-66
pubmed: 18486268
Cancer Biol Med. 2019 Nov;16(4):714-728
pubmed: 31908890
ACS Nano. 2021 Mar 23;15(3):4901-4915
pubmed: 33683878
Ultrasound Med Biol. 2020 Oct;46(10):2579-2604
pubmed: 32713788
Clin Cancer Res. 2020 Mar 1;26(5):1152-1161
pubmed: 31615935
Br J Cancer. 2012 Jul 24;107(3):469-76
pubmed: 22790798
Sci Rep. 2018 Feb 15;8(1):3112
pubmed: 29449656
J Nucl Med. 2012 Mar;53(3):345-8
pubmed: 22393225
Ir J Med Sci. 2021 Feb;190(1):41-57
pubmed: 32607912
J Control Release. 2016 Dec 10;243:172-181
pubmed: 27744037
Pathol Res Pract. 2022 Jan;229:153723
pubmed: 34952426
Curr Pharm Des. 2012;18(15):2184-99
pubmed: 22352772
Ultrason Sonochem. 2022 Jan;82:105882
pubmed: 34969003
Oncoscience. 2015 Dec 15;2(12):944-57
pubmed: 26909363
Nanoscale. 2019 Sep 7;11(33):15647-15658
pubmed: 31408083
Trends Immunol. 2018 Aug;39(8):644-655
pubmed: 30001871
Sci Rep. 2021 Jan 13;11(1):927
pubmed: 33441763
Nat Rev Drug Discov. 2004 Jun;3(6):527-32
pubmed: 15173842
NPJ Breast Cancer. 2020 Mar 12;6:10
pubmed: 32195333
Bioengineered. 2021 Dec;12(1):3000-3013
pubmed: 34180353
Oncol Rev. 2022 Feb 22;16(1):531
pubmed: 35340884
Nat Nanotechnol. 2022 Aug;17(8):891-899
pubmed: 35637356
Biol Chem. 2015 Jun;396(6-7):645-57
pubmed: 25741736
J Exp Clin Cancer Res. 2021 Jun 21;40(1):197
pubmed: 34154610
Korean J Radiol. 2008 Jul-Aug;9(4):291-302
pubmed: 18682666
Cancers (Basel). 2018 Dec 28;11(1):
pubmed: 30597841
Ultrasound Med Biol. 2012 Nov;38(11):1958-69
pubmed: 22980406
Ultrasonics. 2010 Feb;50(2):273-9
pubmed: 19896683
Curr Protein Pept Sci. 2021;22(6):493-504
pubmed: 33583369
Nat Med. 2019 Oct;25(10):1488-1499
pubmed: 31591590
Nat Rev Clin Oncol. 2011 Aug 02;8(10):577-85
pubmed: 21808266
Int J Hyperthermia. 2019 Nov;36(sup1):64-73
pubmed: 31795832
Oncogene. 2003 Sep 1;22(37):5897-906
pubmed: 12947396
Ultrasound Med Biol. 2013 Nov;39(11):1983-90
pubmed: 23993051
Theranostics. 2017 Aug 23;7(15):3608-3623
pubmed: 29109764
J Transl Med. 2010 Jan 27;8:7
pubmed: 20105334
Clinics (Sao Paulo). 2018 Dec 10;73(suppl 1):e557s
pubmed: 30540123
Clin Dev Immunol. 2011;2011:160250
pubmed: 22242035
Int J Med Sci. 2012;9(3):193-9
pubmed: 22408567
Front Mol Biosci. 2014 Nov 17;1:24
pubmed: 25988165
Nanoscale. 2019 Jan 17;11(3):851-855
pubmed: 30601524
Vaccines (Basel). 2015 Aug 27;3(3):662-85
pubmed: 26350600
PLoS One. 2014 Jul 22;9(7):e102343
pubmed: 25051356
Adv Drug Deliv Rev. 2014 Jun;72:144-53
pubmed: 24680708

Auteurs

Deepa Sharma (D)

Physical Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; Departments of Radiation Oncology, and Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.

Kai Xuan Leong (K)

Physical Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada.

Daniel Palhares (D)

Physical Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; Departments of Radiation Oncology, and Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.

Gregory J Czarnota (GJ)

Physical Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; Departments of Radiation Oncology, and Medical Biophysics, University of Toronto, Toronto, Ontario, Canada. Electronic address: gregory.czarnota@sunnybrook.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH